Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy

Mengbo Li1,2,3, Benjamin L Parker3,4, Evangeline Pearson2,3

  • 1School of Mathematics and Statistics, Faculty of Science, The University of Sydney, Sydney, NSW, Australia.

Insights

This study reveals molecular differences in human heart failure, identifying reduced proteins and altered metabolic pathways in ischaemic and dilated cardiomyopathy. It also uncovers gender-specific changes in heart muscle disease.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Studying human heart failure (HF) is limited by poor access to left ventricular myocardium.
  • Ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM) are the most common causes of HF globally.

Purpose of the Study:

  • To gain direct molecular insights into ICM and DCM using a human heart biobank.
  • To identify proteomic and metabolomic differences in heart failure subtypes compared to controls.

Main Methods:

  • Proteomic and metabolomic analyses were performed on 51 left ventricular (LV) samples from 44 cryopreserved human ICM and DCM hearts.
  • Samples were compared to age-, gender-, and BMI-matched healthy donor controls.

Main Results:

  • A significant reduction in serum amyloid A1 protein was observed in ICM hearts.
  • Perturbed thyroid hormone signaling, reduced riboflavin-5-monophosphate, and fructose-6-phosphate were found in both ICM and DCM.
  • Gender-specific alterations in arginine metabolism, mitochondrial substrates, and X chromosome-linked molecules were identified.

Conclusions:

  • This research provides novel molecular insights into ICM and DCM using human heart tissue.
  • The findings highlight potential gender-specific mechanisms in heart failure.
  • An interactive online application offers a publicly available resource for further research.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
325
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
387
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
268
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
214